Back to Journals » Cancer Management and Research » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,722 | Dovepress* | 10,195+ | 1,519 | 11,714 | |
PubMed Central* | 2,527 | 558 | 3,085 | ||
Totals | 12,722 | 2,077 | 14,799 | ||
*Since 19 December 2018 |
View citations on PubMed and Google Scholar